Boston Scientific (BSX) vs Zimmer Biomet (ZBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Zimmer Biomet (ZBH) has outperformed Boston Scientific (BSX) over the past year, losing 10.7% versus a loss of 56.6%. Over five years, BSX leads with a -4.2% price change compared with -37.7% for ZBH. Boston Scientific is the larger company by market cap ($60.93 billion vs $16.95 billion), about 3.6 times the size.
On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 12.4x for Boston Scientific). Zimmer Biomet pays a dividend yielding 1.08%, while Boston Scientific does not currently pay one. Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 8.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | ZBH |
|---|---|---|
| Share price | $42.04 | $88.88 |
| Market cap | $60.93B | $16.95B |
| 1-day change | +1.11% | +0.44% |
| YTD return | -56.39% | -1.59% |
| 1-year return | -56.64% | -10.67% |
| 5-year return | -4.19% | -37.73% |
| P/E ratio (TTM) | 17.02 | 21.57 |
| Forward P/E | 12.43 | 9.80 |
| EPS (TTM) | $2.47 | $4.12 |
| Dividend yield | 0.00% | 1.08% |
| Annual dividend | $0.00 | $0.96 |
| Revenue (latest FY) | $20.07B | $8.23B |
| Revenue growth (YoY) | +19.87% | +7.20% |
| Net income (latest FY) | $2.89B | $705.10M |
| Gross margin | 69.01% | 69.71% |
| Operating margin | 18.00% | 13.34% |
| Net margin | 14.41% | 8.57% |
| 52-week high | $105.65 | $106.88 |
| 52-week low | $41.39 | $79.12 |
| Distance from 52-week high | -60.21% | -16.84% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +42.48% | +20.65% |
| Average volume | 19.71M | 2.16M |
| Shares outstanding | 1.45B | 190.74M |
| Employees | 59,000 | 17,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Boston Scientific is about 3.6 times larger than Zimmer Biomet by market value ($60.93B vs $16.95B).
- ZBH has outperformed BSX by 46.0 percentage points over the past year.
- Zimmer Biomet trades at a higher earnings multiple (21.6x vs 17.0x trailing P/E).
- Zimmer Biomet offers a meaningfully higher dividend yield (1.08% vs 0.00%).
- Boston Scientific is more profitable, keeping 14.4 cents of every revenue dollar as net income versus 8.6 cents for Zimmer Biomet.
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +7.20%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
About Zimmer Biomet
ZBH stock →Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Health Care · Industrial Specialties · 17,000 employees
BSX vs ZBH FAQ
Which is bigger, Boston Scientific or Zimmer Biomet?
Boston Scientific (BSX) is larger, with a market capitalization of $60.93B compared with $16.95B for Zimmer Biomet (ZBH).
Which stock has performed better over the past year, BSX or ZBH?
ZBH returned -10.67% over the past 12 months, compared with -56.64% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or ZBH?
BSX has the lower trailing P/E at 17.0, versus 21.6 for ZBH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or Zimmer Biomet?
Zimmer Biomet pays a dividend yielding 1.08%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and Zimmer Biomet in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Boston Scientific and Industrial Specialties for Zimmer Biomet.